Liraglutide also lowered the chance of
prediabetes developing in adults who started the study with normal blood sugar levels, with 7 percent becoming prediabetic
compared with nearly 20 percent of those receiving placebo.
Older adults with greater levels of purpose in life are less likely to develop type 2 diabetes or
prediabetes over a 4 - year follow - up
compared to older adults with lower levels of purpose in life.